Study of Teduglutide in Japanese Participants With Short Bowel Syndrome
Status:
Completed
Trial end date:
2019-08-06
Target enrollment:
Participant gender:
Summary
The objectives of this clinical study are to evaluate the safety, efficacy, and
pharmacokinetics (PK) of teduglutide in Japanese participants with short bowel syndrome (SBS)
who are dependent on parenteral nutrition/intravenous (PN/IV) over a 24-week treatment
period.